BMC Clin Pharmacol. 2012;12(3):1-8. Acetylcysteine is commonly given before contrast media in patients with renal impairment in an effort to minimise the risk of CIN. Use of this agent is attractive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results